Article | November 14, 2023

The Post-Pandemic Supply Chain: Improving Resilience Via Value Chains

By Andrew Goldman, Head of Business Continuity Management, Lynn Stephenson, PhD., Senior Marketing Manager, Supply Security, and Oliver Prince, PhD., Senior Consultant, Strategy Optimization


The COVID-19 pandemic underscored the vulnerability of global supply chains, revealing the fragility of lean manufacturing techniques and ‘just-in-time’ inventory models. The strain of supply chain disruptions particularly impacted the pharmaceutical industry as it raced to eradicate the virus. Post-pandemic, supply chain resilience is top of mind. The industry is striving to fortify against future supply chain disruptions by developing a robust plan for the unexpected, involving stronger risk management and focus on the value of customers. The emphasis on value chains over supply chains, driven by customer-centric approaches, marks a transformative post-pandemic shift.

Strengthening the resilience of biopharmaceutical supply chains is not merely a business imperative, for patients around the world are relying on the timely delivery of life-changing and life-saving treatments. In this article, you will explore lessons learned from the pandemic, the concept of supply chain resilience, what to look for in a supplier, and much more.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online